2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Colitis, Lymphocytic: new trials by email Literature Review of Colitis, Lymphocytic trials Research Report on Colitis, Lymphocytic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis Budesonide, Mesalamine, Placebo - Lymphocytic Colitis | Phase 3 | Completed | Dr. Falk Pharma GmbH | 57 | 2010-05-01 | 2017-07-26 |
| Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis Placebo, Budesonide - Lymphocytic Colitis, Diarrhea | Phase 2 / Phase 3 | Terminated | Mayo Clinic | 16 | 2003-06-01 | 2021-11-02 |
| Budesonide Treatment for Lymphocytic Colitis Budesonide - Microscopic Colitis | Phase 3 | Completed | Technische Universität Dresden | 40 | 2002-01-01 | 2010-03-30 |
Colitis, Microscopic (1) · Diarrhea (1)
Colitis (3) · Colonic Diseases (3) · Digestive System Diseases (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Colitis, Microscopic (2) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Budesonide (3) · Mesalamine (1)
Dr. Falk Pharma GmbH (1) · Mayo Clinic (1) · Technische Universität Dresden (1)
Germany (2) · United States (1)
Darrell S. Pardi, M.D. (1) · Stephan Miehlke, Prof. (1) · Stephan Miehlke, Professor (1)
2008 (1), UL1RR024150 (1)